Johnson & Johnson to settle talc baby powder investigation, will reportedly pay $700 million

Johnson & Johnson to settle talc baby powder investigation, will reportedly pay 0 million


In this photo illustration, a container of Johnson and Johnson baby powder is displayed on April 05, 2023 in San Anselmo, California. 

Justin Sullivan | Getty Images

Johnson & Johnson has reached a tentative settlement to resolve an investigation by more than 40 states into claims that the company misled patients about the safety of its talc baby powder and other talc-based products, the company said in a statement to CNBC on Tuesday. 

Notably, the settlement does not resolve the tens of thousands of consumer lawsuits, some of which are slated to go to trial this year, alleging that those talc-based products caused cancer.

Those cases have for decades caused financial and public relations trouble for J&J, which contends that its now-discontinued talc products are safe for consumers.

J&J said in an October securities filing that 42 states and Washington, D.C., had launched a joint investigation into its marketing of talc-based products. The company will pay $700 million to settle the probe, its CFO Joseph Wolk told the Wall Street Journal Tuesday.

Last year, J&J only set aside about $400 million to resolve U.S. state consumer protection claims.

Erik Haas, J&J’s worldwide vice president of litigation, confirmed the settlement in a statement to CNBC. He did not provide the payment amount or further details on the deal.

“Consistent with the plan we outlined last year, the company continues to pursue several paths to achieve a comprehensive and final resolution of the talc litigation,” Haas told CNBC. “As was leaked last week, that progress includes an agreement in principle that the Company reached with a consortium of 43 State Attorneys Generals to resolve their talc claims.”

Bloomberg first reported about the settlement earlier this month, citing sources familiar with the matter. 

J&J, which reported fourth-quarter results on Tuesday, has twice tried to resolve the consumer talc cases by offloading those liabilities into a subsidiary, LTL Management, and having that unit file for Chapter 11 bankruptcy protection. 

A New Jersey bankruptcy judge in July rejected the second bankruptcy attempt, stating that LTL Management wasn’t in sufficient financial distress. A U.S. appeals court in April dismissed the first bankruptcy attempt for the same reason. 

As part of the latest failed bankruptcy attempt, J&J proposed to pay $8.9 billion to talc claimants.

J&J said late last year that it is considering a third bankruptcy attempt as it tries to push forward with that proposal.

J&J ended sales of its talc-based baby powder globally last year.



Source

Kennedy sidesteps vaccine questions: ‘I don’t think people should be taking medical advice from me’
Health

Kennedy sidesteps vaccine questions: ‘I don’t think people should be taking medical advice from me’

Health and Human Services Secretary Robert F. Kennedy Jr. on Wednesday sidestepped a question about vaccines and whether he would choose to vaccinate his children today against a number of diseases, saying, “I don’t think people should be taking medical advice from me.” Kennedy’s comment was in response to Rep. Mark Pocan, D-Wis., during a […]

Read More
Healthy Returns: Trump provides a glimpse of the third round of Medicare drug price negotiations
Health

Healthy Returns: Trump provides a glimpse of the third round of Medicare drug price negotiations

In a photo illustration, prescription drugs are seen next to a pill bottle on July 23, 2024 in New York City. Spencer Platt | Getty Images News | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to […]

Read More
FDA moves to take prescription fluoride drops and tablets for kids off the market
Health

FDA moves to take prescription fluoride drops and tablets for kids off the market

Ferlistockphoto | Istock | Getty Images The Food and Drug Administration on Tuesday announced it will begin the process of pulling prescription fluoride drops and tablets for children off the market. The supplements are usually given to kids at high risk for cavities. The federal government and some state legislatures are increasingly drawing attention to what they […]

Read More